IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $12,477,000 | +67.6% | 372,000 | +99.4% | 1.05% | +108.3% |
Q2 2021 | $7,443,000 | +13.8% | 186,600 | +28.3% | 0.50% | +0.2% |
Q1 2021 | $6,541,000 | +26.0% | 145,476 | +58.5% | 0.50% | +8.9% |
Q4 2020 | $5,190,000 | +220.4% | 91,800 | +129.5% | 0.46% | +31.3% |
Q1 2016 | $1,620,000 | -67.8% | 40,000 | -50.7% | 0.35% | -52.3% |
Q4 2015 | $5,029,000 | – | 81,200 | – | 0.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |